Association of Psychiatric Disorders With Mortality Among Patients With COVID-19.

ABSTRACT:

Importance

To date, the association of psychiatric diagnoses with mortality in patients infected with coronavirus disease 2019 (COVID-19) has not been evaluated.

Objective

To assess whether a diagnosis of a schizophrenia spectrum disorder, mood disorder, or anxiety disorder is associated with mortality in patients with COVID-19.

Design, setting, and participants

This retrospective cohort study assessed 7348 consecutive adult patients for 45 days following laboratory-confirmed COVID-19 between March 3 and May 31, 2020, in a large academic medical system in New York. The final date of follow-up was July 15, 2020. Patients without available medical records before testing were excluded.

Exposures

Patients were categorized based on the following International Statis

SUBMITTER: Nemani K 

PROVIDER: S-EPMC7841576 | biostudies-literature | 2021 Apr

REPOSITORIES: biostudies-literature